U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07814560) titled 'Metabolic Syndrome and Risk of Chronic Philadelphia Negative Myeloproliferative Neoplasms' on Sept. 06.
Brief Summary: Studying the role of metabolic syndrome in chronic Myeloproliferative neoplasms (MPNs)
Study Start Date: Dec. 01, 2026
Study Type: OBSERVATIONAL
Condition:
Philadelphia Chromosome Negative Chronic Myelogenous Leukemia
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Mohammad Hasan Mohammad AbdEllah-Alawi, Assiut University
Published by HT Digital Content Services with permission from Health Daily Digest....